The common specifications include 10%, 20%, 40% tanshinone type IIA, 7%,10 %, 20 % Salvianolic acid B and 5%, 10% daiclzein, according herbridge. Which Xi’an Honson Bio-Tech Co., Ltd. has a related patent (it was prepared daiclzein by spray counter-current extraction method of process, application number: 201210086309.8 ;). Now, that main supply the Chinese market, the international market in Japan, South Korea, Taiwan, Singapore, Malaysia and other countries for the demand, Honson told herbridge media. The United States pharmacopoeia included the salvia miltiorrhiza in 2010, which promote the progress of salvia miltiorrhiza products to the U.S. market. The international markets are influenced by Chinese traditional culture largely, so the uses of salvia miltiorrhiza are relatively mature.

There has MVR, reverse osmosis membrane technology, quantum ring water treatment technology, threaded tube heat exchanger, etc. in salvia miltiorrhiza extract production technology, which can significantly reduce the heat to the destruction of the active ingredients, make products to improve the recovery rate of over 25%. As people constantly attach importance to environment, the ingredients of healthy plant extracts that extract from some equipments of energy saving is the trend of the future and the embodiment of the competitiveness.

 

 

Salvia miltiorrhiza has good curative effect in the aspect of prevention and treatment of cardiovascular disease. In accordance with the seasonal weather conditions, the high-incidence season of cardiovascular disease is winter and spring, so it's the salvia miltiorrhiza extract sales season yet. The off season those include autumn and summer, in which factories mainly in equipment testing and small batch production. Under the influence of national policy and the medicine price, salvia miltiorrhiza markets are basically flat in the first half year, compared with previous years; it is expected to that have a big growth in demand after September in 2014.